Literature DB >> 14515192

Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells.

Ellen Bretschneider1, Rainer Spanbroek, Katharina Lötzer, Andreas Johann Richard Habenicht, Karsten Schrör.   

Abstract

The present study investigates whether vascular smooth muscle cells of the human saphenous vein (SMC) express a functionally active protease-activated receptor-3 (PAR-3). PAR-3 mRNA was detected by RT-PCR. In the presence of thrombin, a rapid and transient increase in PAR-3 mRNA was observed. Stimulation of SMC with thrombin or the synthetic PAR-3-activating peptide, TFRGAP, resulted in transient mobilization of intracellular calcium. After a preceding challenge with thrombin, the calcium signal to TFRGAP was abolished, suggesting cleavage and subsequent desensitization of PAR-3 by thrombin. Activation of PAR-3 by TFRGAP elicited a time-dependent activation of the extracellular-signal-regulated kinase (ERK)-1/2 with a maximum response 10-20 min after stimulation. At 200 microM, TFRGAP increased [3H]-thymidine incorporation into cellular DNA about two-fold. These data indicate that PAR-3 is expressed in human SMC and triggers intracellular signaling. Thus, in the SMC PAR-3 might contribute to thrombin-induced responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515192     DOI: 10.1160/TH03-04-0203

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

Review 1.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

2.  Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes.

Authors:  Thati Madhusudhan; Hongjie Wang; Beate K Straub; Elisabeth Gröne; Qianxing Zhou; Khurrum Shahzad; Sandra Müller-Krebs; Vedat Schwenger; Bruce Gerlitz; Brian W Grinnell; John H Griffin; Jochen Reiser; Hermann-Josef Gröne; Charles T Esmon; Peter P Nawroth; Berend Isermann
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

3.  Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis.

Authors:  J Myerson; L He; G Lanza; D Tollefsen; S Wickline
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

Review 4.  Allosteric modulation of protease-activated receptor signaling.

Authors:  I Canto; U J K Soh; J Trejo
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

5.  Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cells.

Authors:  Param Vidwan; Alokkumar Pathak; Samar Sheth; Jianhua Huang; Dougald M Monroe; George A Stouffer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-07       Impact factor: 8.311

6.  Proteinase-activated receptors differentially modulate in vitro invasion of human pancreatic adenocarcinoma PANC-1 cells in correlation with changes in the expression of CDC42 protein.

Authors:  Liora Segal; Liora S Katz; Monica Lupu-Meiri; Hagit Shapira; Judith Sandbank; Marvin C Gershengorn; Yoram Oron
Journal:  Pancreas       Date:  2014-01       Impact factor: 3.327

7.  Thrombin-mediated increases in cytosolic [Ca2+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells.

Authors:  Richard S Sacks; Amy L Firth; Carmelle V Remillard; Negin Agange; Jocelyn Yau; Eun A Ko; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-03       Impact factor: 5.464

8.  A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist.

Authors:  Juliet Mwirigi; Moeno Kume; Shayne N Hassler; Ayesha Ahmad; Pradipta R Ray; Changyu Jiang; Alexander Chamessian; Nakleh Mseeh; Breya P Ludwig; Benjamin D Rivera; Marvin T Nieman; Thomas Van de Ven; Ru-Rong Ji; Gregory Dussor; Scott Boitano; Josef Vagner; Theodore J Price
Journal:  J Pain       Date:  2021-01-09       Impact factor: 5.383

9.  Induction of release and up-regulated gene expression of interleukin (IL)-8 in A549 cells by serine proteinases.

Authors:  Haiyan Wang; Yanshan Zheng; Shaoheng He
Journal:  BMC Cell Biol       Date:  2006-05-15       Impact factor: 4.241

10.  Activation of protease-activated receptors (PARs)-1 and -2 promotes alpha-smooth muscle actin expression and release of cytokines from human lung fibroblasts.

Authors:  Nithiananthan Asokananthan; Rommel S Lan; Peter T Graham; Anthony J Bakker; Ana Tokanović; Geoffrey A Stewart
Journal:  Physiol Rep       Date:  2015-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.